Luigi Aurisicchio

Company: Neomatrix

Job title: Chief Executive Officer

Seminars:

Neomatrix: An Innovative, Fully-Synthetic DNA Platform for Next Generation Cancer Vaccines 2:00 pm

Evaluating how neoantigen identification is key for the design of personalised cancer vaccines and the requirements of prediction algorithm Enhancing a fast and reliable manufacturing technology and how synthetic DNA allowed the production of NCV in few days, without complex upstream and downstream procedures Investigating a efficient delivery method by using Electroporation which enhances gene…Read more

day: Day Two